---
pmid: '22093366'
title: 'It all comes together at the ends: telomerase structure, function, and biogenesis.'
authors:
- Podlevsky JD
- Chen JJ
journal: Mutat Res
year: '2012'
full_text_available: false
pmcid: PMC4420735
doi: 10.1016/j.mrfmmm.2011.11.002
---

# It all comes together at the ends: telomerase structure, function, and biogenesis.
**Authors:** Podlevsky JD, Chen JJ
**Journal:** Mutat Res (2012)
**DOI:** [10.1016/j.mrfmmm.2011.11.002](https://doi.org/10.1016/j.mrfmmm.2011.11.002)
**PMC:** [PMC4420735](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4420735/)

## Abstract

1. Mutat Res. 2012 Feb 1;730(1-2):3-11. doi: 10.1016/j.mrfmmm.2011.11.002. Epub 
2011 Nov 7.

It all comes together at the ends: telomerase structure, function, and 
biogenesis.

Podlevsky JD(1), Chen JJ.

Author information:
(1)Department of Chemistry & Biochemistry, Arizona State University, Tempe, AZ 
85287-1604, USA.

Telomerase is a reverse transcriptase specialized in the addition of telomeric 
DNA repeats onto the ends of chromosomes. Telomere extension offsets the loss of 
telomeric repeats from the failure of DNA polymerases to fully replicate linear 
chromosome ends. Telomerase functions as a ribonucleoprotein, requiring an 
integral telomerase RNA (TR) component, in addition to the catalytic telomerase 
reverse transcriptase (TERT). Extensive studies have identified numerous 
structural and functional features within the TR and TERT essential for 
activity. A number of accessory proteins have also been identified with various 
functions in enzyme biogenesis, localization, and regulation. Understanding the 
molecular mechanism of telomerase function has significance for the development 
of therapies for telomere-mediated disorders and cancer. Here we review 
telomerase structural and functional features, and the techniques for assessing 
telomerase dysfunction.

Copyright Â© 2011 Elsevier B.V. All rights reserved.

DOI: 10.1016/j.mrfmmm.2011.11.002
PMCID: PMC4420735
PMID: 22093366 [Indexed for MEDLINE]

Conflict of interest statement: Conflicts of Interest None.
